Literature DB >> 17024531

A laparoscopic approach to partial splenectomy for children with hereditary spherocytosis.

S Dutta1, V E Price, V Blanchette, J C Langer.   

Abstract

BACKGROUND: Partial splenectomy is sometimes used for children with hereditary spherocytosis (HS) to reduce hemolysis while retaining some splenic immune function. Previous reports have described a partial splenic resection through a laparotomy incision. Whereas laparoscopic total splenectomy for HS is well-established, laparoscopic partial splenectomy (LPS) has not been described. The authors have developed a novel LPS technique that combines the benefits of partial splenectomy with those of a laparoscopic approach.
METHODS: A chart review was conducted for three children with HS who underwent LPS, with approximately one-fourth of the spleen left on the basis of the short gastric arterial supply.
RESULTS: The mean preoperative spleen size was 17.6 cm. The mean preoperative hemoglobin count was 100 g/l, and the postoperative hemoglobin count was 133 g/l. All three patients reported reduced malaise and increased energy levels. There was no recurrent anemia at the 1- to 2-year follow-up evaluation.
CONCLUSION: The LPS procedure is a safe and effective approach to HS that resolves anemia, potentially retains some splenic immunity, and confers the benefits of a minimal access technique.

Entities:  

Mesh:

Year:  2006        PMID: 17024531     DOI: 10.1007/s00464-006-0131-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  28 in total

1.  Technique for laparoscopic partial splenectomy.

Authors:  P A Seshadri; E C Poulin; J Mamazza; C M Schlachta
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2000-04       Impact factor: 1.719

2.  Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children.

Authors:  Henry E Rice; Keith T Oldham; Cheryl A Hillery; Michael A Skinner; Sara M O'Hara; Russell E Ware
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

3.  Genetics of spherocytosis.

Authors:  N E MORTON; A A MACKINNEY; N KOSOWER; R F SCHILLING; M P GRAY
Journal:  Am J Hum Genet       Date:  1962-06       Impact factor: 11.025

4.  Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis.

Authors:  B Bader-Meunier; F Gauthier; F Archambaud; T Cynober; F Miélot; J P Dommergues; J Warszawski; N Mohandas; G Tchernia
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

Review 5.  Effectiveness of partial splenectomy in hereditary spherocytosis.

Authors:  G Tchernia; B Bader-Meunier; P Berterottiere; S Eber; J P Dommergues; F Gauthier
Journal:  Curr Opin Hematol       Date:  1997-03       Impact factor: 3.284

6.  Beware of the dog: meningitis in a splenectomised woman.

Authors:  M J Krol-van Straaten; J E Landheer; C E de Maat
Journal:  Neth J Med       Date:  1990-06       Impact factor: 1.422

Review 7.  The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto.

Authors:  Victoria E Price; Sanjeev Dutta; Victor S Blanchette; Sheila Butchart; Melanie Kirby; Jacob C Langer; E Lee Ford-Jones
Journal:  Pediatr Blood Cancer       Date:  2006-05-01       Impact factor: 3.167

8.  Capnocytophaga canimorsus sepsis presenting as an acute abdomen in an asplenic patient.

Authors:  P Deprés-Brummer; J Buijs; K C van Engelenburg; H R Oosten
Journal:  Neth J Med       Date:  2001-11       Impact factor: 1.422

9.  Partial splenectomy in children under 4 years of age with hemoglobinopathy.

Authors:  O Idowu; A Hayes-Jordan
Journal:  J Pediatr Surg       Date:  1998-08       Impact factor: 2.545

10.  Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis.

Authors:  G Tchernia; F Gauthier; F Mielot; J P Dommergues; J Yvart; J A Chasis; N Mohandas
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

View more
  9 in total

1.  Laparoscopic versus robotic subtotal splenectomy in hereditary spherocytosis. Potential advantages and limits of an expensive approach.

Authors:  Catalin Vasilescu; Oana Stanciulea; Stefan Tudor
Journal:  Surg Endosc       Date:  2012-04-05       Impact factor: 4.584

2.  Laparoscopic subtotal splenectomy in hereditary spherocytosis.

Authors:  C Vasilescu; O Stanciulea; C Arion
Journal:  Surg Endosc       Date:  2007-09       Impact factor: 4.584

Review 3.  Hereditary spherocytosis and partial splenectomy in children: review of surgical technique and the role of imaging.

Authors:  Caroline L Hollingsworth; Henry E Rice
Journal:  Pediatr Radiol       Date:  2010-02-24

4.  Role of laparoscopic partial splenectomy for tumorous lesions of the spleen.

Authors:  Soo Ho Lee; Jun Suh Lee; Young Chul Yoon; Tae Ho Hong
Journal:  J Gastrointest Surg       Date:  2015-04-03       Impact factor: 3.452

5.  Feasibility and Safety of Laparoscopic Partial Splenectomy: A Systematic Review.

Authors:  Gangshan Liu; Ying Fan
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

6.  Feasibility and safety of minilaparoscopy-guided spleen biopsy.

Authors:  Yunqiang Cai; Xubao Liu
Journal:  Surg Endosc       Date:  2013-03-12       Impact factor: 4.584

7.  Laparoscopic partial splenectomy using a detachable clamp with and without partial splenic embolisation.

Authors:  Maciej Patrzyk; Anne Glitsch; Andreas Hoene; Wolfram von Bernstorff; Claus Dieter Heidecke
Journal:  Langenbecks Arch Surg       Date:  2010-08-05       Impact factor: 3.445

Review 8.  Partial splenectomy in the era of minimally invasive surgery: the current laparoscopic and robotic experiences.

Authors:  Alexandre Balaphas; Nicolas C Buchs; Jeremy Meyer; Monika E Hagen; Philippe Morel
Journal:  Surg Endosc       Date:  2015-03-05       Impact factor: 4.584

9.  Partial splenectomy for benign splenic cysts with the aid of a Lin clamp: technical note.

Authors:  Shih-Chung Wu; Chih-Chi Wang; Chee-Chien Yong
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.